CGAS and neoplasm: By enhancing MOMP-induced inflammation through caspase inhibition, we and others have shown that engaging CICD in tumour cells can lead to anti-tumour immunity dependent on cGAS-STING and NF-κB signalling in the dying cell (Giampazolias et al, 2017; Han et al, 2020).